MOLECULAR PARTNERS AG -ADR (MOLN) Stock Overview
NASDAQ:MOLN - US60853G1067 - ADR
MOLN Key Statistics, Chart & Performance
The current stock price of MOLN is 3.75 USD. In the past month the price decreased by -5.06%. In the past year, price decreased by -33.98%.
MOLN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.87 | 371.68B | ||
| AMGN | AMGEN INC | 13.19 | 154.89B | ||
| GILD | GILEAD SCIENCES INC | 14.6 | 140.17B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.08 | 100.25B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.72 | 61.55B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 58.53B | ||
| ARGX | ARGENX SE - ADR | 76.83 | 43.59B | ||
| ONC | BEONE MEDICINES LTD-ADR | 6.16 | 36.38B | ||
| INSM | INSMED INC | N/A | 28.77B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.04B | ||
| NTRA | NATERA INC | N/A | 23.09B | ||
| BIIB | BIOGEN INC | 8.26 | 19.38B |
Related stock screener links
About MOLN
Company Profile
Molecular Partners AG engages in the provision of development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. The company is headquartered in Schlieren, Zuerich and currently employs 159 full-time employees. The company went IPO on 2014-10-22. The firm has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
Company Info
MOLECULAR PARTNERS AG -ADR
Wagistrasse 14
Schlieren ZUERICH CH
CEO: Patrick Amstutz
Employees: 159
Phone: 41447557700
MOLECULAR PARTNERS AG -ADR / MOLN FAQ
What is the stock price of MOLECULAR PARTNERS AG -ADR today?
The current stock price of MOLN is 3.75 USD. The price increased by 4.16% in the last trading session.
What is the ticker symbol for MOLECULAR PARTNERS AG -ADR stock?
The exchange symbol of MOLECULAR PARTNERS AG -ADR is MOLN and it is listed on the Nasdaq exchange.
On which exchange is MOLN stock listed?
MOLN stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for MOLECULAR PARTNERS AG -ADR stock?
9 analysts have analysed MOLN and the average price target is 13.01 USD. This implies a price increase of 246.83% is expected in the next year compared to the current price of 3.75. Check the MOLECULAR PARTNERS AG -ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is MOLECULAR PARTNERS AG -ADR worth?
MOLECULAR PARTNERS AG -ADR (MOLN) has a market capitalization of 138.28M USD. This makes MOLN a Micro Cap stock.
How many employees does MOLECULAR PARTNERS AG -ADR have?
MOLECULAR PARTNERS AG -ADR (MOLN) currently has 159 employees.
What are the support and resistance levels for MOLECULAR PARTNERS AG -ADR (MOLN) stock?
MOLECULAR PARTNERS AG -ADR (MOLN) has a support level at 3.74 and a resistance level at 4.17. Check the full technical report for a detailed analysis of MOLN support and resistance levels.
Is MOLECULAR PARTNERS AG -ADR (MOLN) expected to grow?
The Revenue of MOLECULAR PARTNERS AG -ADR (MOLN) is expected to decline by -75% in the next year. Check the estimates tab for more information on the MOLN EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy MOLECULAR PARTNERS AG -ADR (MOLN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MOLN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MOLN, evaluating the profitability, health, valuation and growth aspects
- MOLECULAR PARTNERS AG -ADR (MOLN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MOLECULAR PARTNERS AG -ADR (MOLN) Sales and EPS estimates to see what analysts future expectations are.
- MOLECULAR PARTNERS AG -ADR (MOLN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MOLECULAR PARTNERS AG -ADR (MOLN) Insider and Institutional Ownership to learn about the owners and their transactions.
- MOLECULAR PARTNERS AG -ADR (MOLN) Stock Chart to make your own analysis
- MOLECULAR PARTNERS AG -ADR (MOLN) Latest news and press-releases to stay up to date.
Does MOLECULAR PARTNERS AG -ADR (MOLN) stock pay dividends?
MOLN does not pay a dividend.
What is the Price/Earnings (PE) ratio of MOLECULAR PARTNERS AG -ADR (MOLN)?
MOLECULAR PARTNERS AG -ADR (MOLN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.92).
What is the Short Interest ratio of MOLECULAR PARTNERS AG -ADR (MOLN) stock?
The outstanding short interest for MOLECULAR PARTNERS AG -ADR (MOLN) is 0.1% of its float. Check the ownership tab for more information on the MOLN short interest.
MOLN Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to MOLN. When comparing the yearly performance of all stocks, MOLN is a bad performer in the overall market: 88.63% of all stocks are doing better.
MOLN Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to MOLN. MOLN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
MOLN Financial Highlights
Over the last trailing twelve months MOLN reported a non-GAAP Earnings per Share(EPS) of -0.92. The EPS increased by 40.75% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -34.09% | ||
| ROE | -38.16% | ||
| Debt/Equity | 0.01 |
MOLN Forecast & Estimates
9 analysts have analysed MOLN and the average price target is 13.01 USD. This implies a price increase of 246.83% is expected in the next year compared to the current price of 3.75.
For the next year, analysts expect an EPS growth of 7.01% and a revenue growth -75% for MOLN